Comparison of Current Diagnostic Criteria for Acute-On-Chronic Liver Failure

Background and Aims Currently, acute-on-chronic liver failure (ACLF) has been defined differently by Asia–Pacific Association for the Study of the Liver (APASL) and Chinese Medical Association (CMA) in the East, as well as EASL-Chronic Liver Failure (EASL-CLIF) Consortium in the West. This study aimed to compare current different diagnostic criteria for ACLF and to determine predictors of the progression into post-enrollment EASL-CLIF ACLF from ACLF at enrollment defined by APASL alone or by both APASL and CMA but not by EASL-CLIF Consortium. Methods We retrospectively analyzed clinical data from 394 eligible cirrhotic patients fulfilling at least APASL criteria for ACLF at enrollment. Patient survival was estimated by Kaplan-Meier analysis and subsequently compared by log-rank test. Independent predictors of disease progression were determined using univariate analysis and multivariate Cox regression analysis. Results The 90-day mortality rate was 13.1% in patients with ACLF at enrollment defined by APASL alone, 25.3% in patients with ACLF at enrollment defined by both APASL and CMA but not EASL-CLIF Consortium, and 59.3% in patients with ACLF at enrollment defined by EASL-CLIF Consortium in addition to APASL. Baseline Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA) score, and the maximum rising rates of CLIF-SOFA score, Model for End-Stage Liver Disease-Sodium (MELD-Na) score and total bilirubin were independent predictors of progression into post-enrollment EASL-CLIF ACLF from ACLF at enrollment defined by APASL alone or by both APASL and CMA but not by EASL-CLIF Consortium. Conclusion Different diagnostic criteria for ACLF caused different patient prognosis. So, it is imperative to formulate a unifying diagnostic criteria for ACLF worldwide, thus attaining early identification and treatment, and eventual improvement in survival of ACLF patients. Baseline CLIF-SOFA score, and the maximum rising rates of CLIF-SOFA score, MELD-Na score and total bilirubin may early predict post-enrollment development of EASL-CLIF ACLF.

[1]  R. Moreau,et al.  Acute-on-chronic liver failure: a new clinical entity. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  H. Lui,et al.  Change in model for end-stage liver disease score at two weeks, as an indicator of mortality or liver transplantation at 60 days in acute-on-chronic liver failure , 2014, Gastroenterology report.

[3]  E. Hassan,et al.  A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience. , 2013, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

[4]  Min Zhang,et al.  Dynamic Changes of Clinical Features that Predict the Prognosis of Acute-on-Chronic Hepatitis B Liver Failure: A Retrospective Cohort Study , 2013, International journal of medical sciences.

[5]  Lanjuan Li,et al.  A Modified MELD Model for Chinese Pre-ACLF and ACLF Patients and It Reveals Poor Prognosis in Pre-ACLF Patients , 2013, PloS one.

[6]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[7]  J. Bajaj.  Defining acute-on-chronic liver failure: will East and West ever meet? , 2013, Gastroenterology.

[8]  Liver Failure,et al.  [Diagnostic and treatment guidelines for liver failure (2012 version)]. , 2013, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[9]  P. Kamath,et al.  Acute-on chronic liver failure. , 2012, Journal of hepatology.

[10]  R. Jalan,et al.  Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study , 2012, Critical Care.

[11]  S. Fuchs,et al.  MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil , 2012, Clinical transplantation.

[12]  H. Garg,et al.  Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[13]  P. Kamath,et al.  Intensive care of the patient with cirrhosis , 2011, Hepatology.

[14]  J. Chen,et al.  Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. , 2011, World journal of gastroenterology.

[15]  F. Nevens,et al.  Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions , 2011, Expert review of gastroenterology & hepatology.

[16]  P. Kamath,et al.  Acute-on-chronic liver failure: concept, natural history, and prognosis , 2011, Current opinion in critical care.

[17]  F. Lee,et al.  Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[18]  Ming-jun Sun,et al.  Validation of model for end‐stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis , 2009, Journal of gastroenterology and hepatology.

[19]  Y. Chawla,et al.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 , 2009, Hepatology International.

[20]  T. Therneau,et al.  Hyponatremia and mortality among patients on the liver-transplant waiting list. , 2008, The New England journal of medicine.

[21]  P. Ginès,et al.  Hyponatremia in cirrhosis: Pathogenesis, clinical significance, and management , 2008, Hepatology.

[22]  T. Therneau,et al.  Evidence-based incorporation of serum sodium concentration into MELD. , 2006, Gastroenterology.

[23]  E. Cholongitas,et al.  Risk factors, Sequential Organ Failure Assessment and Model for End‐stage Liver Disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit , 2006, Alimentary pharmacology & therapeutics.

[24]  W. Kremers,et al.  Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  Adnan Said,et al.  Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. , 2004, Journal of hepatology.

[26]  M. Tsai,et al.  Multiple Organ System Failure in Critically Ill Cirrhotic Patients , 2004, Digestion.

[27]  P. Kamath,et al.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.

[28]  M. Py.  Pathogenesis of sodium and water retention in cirrhosis of the liver , 1997 .

[29]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[30]  M. Ronsoni,et al.  The performance of prognostic models as predictors of mortality in patients with acute decompensation of cirrhosis. , 2015, Annals of hepatology.

[31]  A. Abu-Hanna,et al.  UvA-DARE ( Digital Academic Repository ) Acute liver failure and acute kidney injury : Definitions , prognosis , and outcome , 2013 .

[32]  Y. Chawla,et al.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) , 2009, Hepatology international.

[33]  P. Martin.  [Pathogenesis of sodium and water retention in cirrhosis of the liver]. , 1997, Praxis.